¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"late phase reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • leptotene phase
    °¡´Â¼¶À¯±â, ¼¼»ç±â
  • logarithmic phase
    ´ë¼öÁõ½Ä±â
  • lactiferous phase
    ¼öÀ¯±â
  • luteal phase
    Ȳ(»ö)ü±â
  • luteal phase defect
    Ȳ(»ö)ü±â°á¼Õ
  • luteal phase endometrial biopsy
    Ȳ(»ö)ü±âÀڱ󻸷»ý°Ë
  • lysogenic phase
    ¿ë¿ø±â
  • mitosis phase
    À¯»çºÐ¿­±â
  • modulation phase
    º¯Á¶À§»ó
  • manic phase
    Á¶Áõ±â, µé¶ä±â
  • menstrual phase
    ¿ù°æ±â
  • negative phase
    1. À½¼º»ó 2. Ç×ü°¨¼Ò±â
  • oral phase
    ±¸°­±â
  • orgasmic phase
    ¼º±ØÄ¡±â
  • ovogenetic phase
    ³­Àڹ߻ý±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
  • reversible reaction
    °¡¿ª¹ÝÀÀ
  • second order reaction
    ÀÌÂ÷¹ÝÀÀ
  • second set reaction
    ÀÌÂ÷°ÅºÎ¹ÝÀÀ
  • setting reaction
    ÀÀ°í¹ÝÀÀ
  • skin reaction
    ÇǺιÝÀÀ
  • static reaction
    Á¤Àû¹ÝÀÀ, ÆòÇü¹ÝÀÀ
  • stress reaction
    ½ºÆ®·¹½º¹ÝÀÀ
  • systemic reaction
    Àü½Å¹ÝÀÀ
  • transfusion reaction
    ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ
  • reaction substance
    ¹ÝÀÀ¹°Áú
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
  • reaction time
    ¹ÝÀÀ½Ã°£
  • reaction threshold
    ¹ÝÀÀ¹®Åΰª, ¹ÝÀÀ¿ªÄ¡
  • reaction velocity
    ¹ÝÀÀ¼Óµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • phase encoding
    À§»óºÎȣȭ
  • phase shift effect
    À§»óº¯À§È¿°ú
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • phase boundary force
    »ó°èÀü·Â
  • growth phase
    Áõ½Ä±â
  • phase encoding gradient
    À§»óºÎȣȭ±â¿ï±â
  • implantational phase
    Âø»ó±â
  • in-phase image
    À§»ó³»¿µ»ó
  • inflow phase
    À¯ÀÔ±â
  • inspiratory phase
    Èí±â»ó
  • inspiratory phase time
    µé¼û½Ã°£, Èí±â½Ã°£
  • internal phase
    ³»»ó
  • intuitive phase
    Á÷°ü±â
  • involutional phase
    ÅðÈ­±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • phase constant
    À§»ó»ó¼ö(êÈßÓßÈâ¦).
  • phase contrast
    À§»ó ´ëÁ¶
  • phase contrast (PC) MR angiography
    À§»ó ´ëÁ¶ ÀÚ±â°ø¸í Ç÷°üÁ¶¿µ¼ú
  • phase contrast microscopy
    À§»óÂ÷(êÈßÓó¬)Çö¹Ì°æ°Ë»ç
  • phase curve
    À§»ó °î¼±
  • phase delay
    »óÁö¿¬(ßÓòÀæÅ)
  • phase difference
    À§»óÂ÷(êÈßÓó¬).
  • phase difference
    À§»óÂ÷
  • phase difference haploscope
    À§»óÂ÷ÇÏÇ÷νºÄÚ¿ìÇÁ
  • phase display
    À§»ó Ç¥½Ã
  • phase encode direction
    À§»ó ºÎȣȭ ¹æÇâ
  • phase encoding
    À§»ó ºÎȣȭ
  • phase encoding gradient
    À§»ó ºÎȣȭ °æ»çµµ
  • phase encoding gradient
    À§»ó ºÎȣȭ °æ»çÀå
  • phase encoding step
    À§»ó ºÎÈ£ ´Ü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cephalic phase
    ³ú»ó(ÒàßÓ)
  • circadian-phase intervention
    ÀÏÁÖ±â-»ó ÁßÀç(ìíñÎÑ¢-ßÓ ñêî®)
  • colostral phase
    ÃÊÀ¯±â
  • compression phase
    ¾ÐÃà»ó
  • death phase
    »ç¸ê±â
  • delayed sleep phase
    Áö¿¬¼º ¼ö¸é»ó(òÀæÅàõ â²ØùßÓ)
  • delayed sleep phase syndrome
    Áö¿¬¼º ¼ö¸é»ó ÁõÈıº(òÀæÅàõ â²ØùßÓ ñøý¦ÏØ)
  • depressive phase
    ¿ì¿ï»ó(éØê¦ßÓ)
  • diastolic phase
    È®Àå±â(üªíåÑ¢).
  • diplotene phase
    °ã¼¶À¯±â
  • diurnal phase
    ÁÖ°£»ó(ñÎÊàßÓ)
  • ejection phase
    ¹ÚÃâ±â(ÚÑõóÑ¢).
  • ejection phase
    ¹ÚÃâ±â.
  • equilibrium phase
    ÆòÇü±â
  • erythrocytic phase
    ÀûÇ÷±¸³»¹ßÀ°±â(?ËÑËôË»).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • alarm reaction
    °æÁ¾¹ÝÀÀ (Ìíñ¤Úãëë)
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã½º¾ç(åÆ) ¹ÝÀÀ(Úãëë)
  • anaplerotic reaction
    º¸Àü¹ÝÀÀ(ÜÍîóÚãëë)
  • annulation reaction
    ȯ»óÇü¼º ¹ÝÀÀ(ü»ßÒû¡à÷Úãëë)
  • anthrone reaction
    ¾ÈÆ®·Ð ¹ÝÀÀ(Úãëë)
  • antigen-antibody reaction
    Ç׿øÇ×ü ¹ÝÀÀ(ù÷ê«ù÷ô÷Úãëë)
  • Arthus reaction
    ¾Æ¸£Åõ½º ¹ÝÀÀ(Úãëë)
  • Berthelot reaction
    º£¸£ÅÐ·Ô ¹ÝÀÀ(Úãëë)
  • Bial's reaction
    ºñ¾Ë ¹ÝÀÀ(Úãëë)
  • bimolecular reaction
    À̺ÐÀÚ ¹ÝÀÀ(ì£ÝÂí­Úãëë)
  • bireactant reaction
    µÎ ¹ÝÀÀ¹°(ÚãëëÚª) ¹ÝÀÀ(Úãëë)
  • bisubstrate reaction
    µÎ ±âÁú(Ðñòõ) ¹ÝÀÀ(Úãëë)
  • biuret reaction
    ºß·¿ ¹ÝÀÀ(Úãëë)
  • capsule swelling reaction
    ĸ½¶ ÆØÃ¢¹ÝÀÀ(ø³óìÚãëë)
  • Carr-Price reaction
    Ä«¸£-ÇÁ¶óÀ̽º ¹ÝÀÀ(Úãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • phase wrap
    À§»óÆ÷Àå
  • phase wraparound
    À§»óÆ÷Àå
  • phase wraparound artifact
    À§»óÆ÷ÀåÀΰø¹°
  • portal phase
    ¹®¸Æ±â
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • resting phase
    È޽ıâ
  • spin phase
    ½ºÇÉÀ§»ó
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • test phase
    ½ÃÇè±â
  • venous phase
    Á¤¸Æ»ó, Á¤¸Æ±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
IR drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat...
NR do not repeat [Lat. non repetatur]; nerve root; neural retina; neutral red; noise reduction; nonreac...
PTR patellar tendon reflex; patient termination record; patient to return; peripheral total resistance; ...
SGR Sachs-Georgi reaction; Shwartzman generalized reaction; skin galvanic reflex; submandibular gland re...
WFR Weil-Felix reaction; wheal-and-flare reaction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
LPC Late Positive Component
LAR Late asthmatic response
LINCL Late infantile neuronal ceroid lipofuscinosis
LVP Late ventricular potentials
mlp Major Late Promoter
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phase encoding
    À§»ó ºÎȣȭ
  • phase encoding step
    À§»ó ºÎÈ£ ´Ü°è
  • phase frequency swap
    À§»ó Á֯ļö ±³È¯
  • phase II treatment
    Á¦2´Ü°è Ä¡·á
  • phase mismapping
    À§»ó ¿ÀÁöµµ ÀÛ¼º
  • phase of meditation
    Àẹ ±â°£
  • phase ratio
    »óºñ
  • phase shift
    À§»ó º¯À§
  • phase shift effect
    À§»ó º¯À§ È¿°ú
  • phase wrap
    À§»ó Æ÷Àå
  • phase wraparound artifact
    À§»ó Æ÷Àå Àΰø¹°
  • portal phase
    ¹®¸Æ±â
  • preeruptive phase
    ¸ÍÃâÀü ´Ü°è
  • prefunctional eruptive phase
    ±â´ÉÀü ¸ÍÃ⠴ܰè
  • premenstrual :

    premenstrual phase

    ¿ù°æ Àü±â
    ¿ù°æÀÌ °³½ÃÇÏ´Â Á÷Àü ½Ã±â.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
phase Any one of the varying aspects or stages through which a disease or process may pass.
Origin: Gr. Phasis = an appearance
(18 Nov 1997)
phase-amplitude contrast <microscopy> The separation and recombination of direct vs. Diffracted rays in a light microscope adjusted to Kohler illumination. at the lower focal plane of the condenser there is an annular diaphragm with an opaque central stop. Through this diaphragm rays are focused as a hollow cone onto the specimen. In the back focal plane of the objective there is a conjugate annular diaphragm (phase plate). If here the undiffracted rays are retarded (by a transparent film of proper thickness on the annulus of the phase plate), bright contrast results. If, instead, the phase-delay film is on the central spot, dark contrast results. With either a bright or a dark-contrast phase plate, the annulus is usually coated with a partially absorbing (very thin) film of silver (Zernike method) or carbon soot (Wilska method) to reduce the higher amplitude (intensity) of the undiffracted rays.
(05 Aug 1998)
phase angle <microscopy> The angular equivalent of the time displacement between corresponding points on two sine waves of the same frequency.
(05 Aug 1998)
phase contrast <microscopy> An optical method devised by F. Zernike for converting the focused image of a phase object (one with differences in refractive index or optical path but not in absorbance), which ordinarily is not visible in focus, into an image with good contrast.
(05 Aug 1998)
phase-contrast microscope <instrument> A specially constructed microscope that has a special condenser and objective containing a phase-shifting ring whereby small differences in index of refraction are made visible as intensity or contrast differences in the image; particularly useful for examining structural details in transparent specimens such as living or unstained cells and tissues.
(05 Mar 2000)
phase contrast microscopy <investigation> A simple nonquantitative form of interference micoscopy of great utility in visualising live cells. Small differences in optical path length due to differences in refractive index and thickness of structures are visualised as differences in light intensity.
(18 Nov 1997)
phase, crystal <microscopy> A specific crystal structure, usually given a name.
(05 Aug 1998)
phase encoding In magnetic resonance imaging, the technique of inducing a gradient in the magnetic field in the Y-axis to induce phase differences with location.
Synonym: gradient encoding.
(05 Mar 2000)
phase I block Inhibition of nerve impulse transmission across the myoneural junction associated with depolarisation of the motor endplate, as in the muscle paralysis produced by succinylcholine.
(05 Mar 2000)
phase I clinical trial <pharmacology> The earliest stage clinical trial for studying an experimental drug in humans. Phase I trials are generally comparatively small and are used to determine toxicity and maximum dose.
They provide an initial evaluation of a drug's safety and pharmacokinetics-how the drug is absorbed, what tissues it reaches and how long it takes to leave the body. Such studies also usually test various doses of the drug (dose-ranging) to obtain an indication of the appropriate dose to use in later studies.
The patients in these trials usually have advanced disease and have already received best available chemotherapy, therefore, seeing a repose is significant partially because this means there is a lack of cross-resistance between two anti-cancer drugs.
(31 Dec 1997)
phase II block Inhibition of nerve impulse transmission across the myoneural junction unaccompanied by depolarisation of the motor endplate, as in the muscle paralysis produced by tubocurarine.
(05 Mar 2000)
phase II clinical trial <pharmacology> Usually focus on the activity of the new product as a single agent in a noncomparative, open study.
(31 Dec 1997)
phase III clinical trial <pharmacology> An advanced stage clinical trial that should conclusively show how well a drug works as compared to other treatments.
Phase III trials are large, frequently multi-institution tests. They generally compare the relative value of the new drug compared with the current standard treatment and measure whether a new drug extends survival or otherwise improves the health of patients on treatment (clinical improvement) rather than just provide surrogate marker data. These studies generally last longer and are larger than phase II trials.
(31 Dec 1997)
phase image A magnetic resonance image showing only phase shift information, to detect motion.
(05 Mar 2000)
phase plate <microscopy> The plate used near the back focal plane of a microscope objective lens (in conjunction with an annulus at the front focal plane of the condenser lens) to achieve phase contrast. The phase plate selectively shifts the phase of the waves diffracted by the specimen by a quarter wave and reduces the amplitude of the undeviated, direct beam.
(05 Aug 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á